Zentalis Pharmaceuticals, Inc. (ZNTL) Misses Q2 EPS by 11c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q2 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
• Smith Micro Software (SMSI) Misses Q2 EPS by 2c
• Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c